NasdaqCM - Delayed Quote USD
IM Cannabis Corp. (IMCC)
3.4800
-2.7200
(-43.87%)
At close: June 2 at 4:00:01 PM EDT
3.3300
-0.15
(-4.31%)
After hours: June 2 at 7:59:52 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
54,468
54,031
48,804
54,335
34,053
Cost of Revenue
44,348
45,580
38,958
45,173
27,720
Gross Profit
10,120
8,451
9,846
9,162
6,333
Operating Expense
14,566
18,685
22,021
31,665
29,368
Operating Income
-4,446
-10,234
-12,175
-22,503
-23,035
Net Non Operating Interest Income Expense
-2,071
-2,560
3,335
4,731
22,871
Other Income Expense
--
--
-617
-8,288
--
Pretax Income
-6,517
-12,794
-9,457
-26,060
-164
Tax Provision
-941
-1,023
771
-1,138
500
Net Income Common Stockholders
-4,390
-10,585
-9,498
-188,890
-17,763
Diluted NI Available to Com Stockholders
-4,390
-10,585
-9,498
-188,890
-17,763
Basic EPS
-1.90
-4.51
-4.45
-157.80
-18.60
Diluted EPS
-1.90
-4.51
-4.45
-161.88
-39.60
Basic Average Shares
3,085.4520
2,349.2210
2,136.5490
1,197.0220
955
Diluted Average Shares
3,085.4520
2,349.2210
2,136.5490
1,197.0220
955
Total Operating Income as Reported
-4,446
-10,234
-12,792
-30,791
-23,035
Total Expenses
58,914
64,265
60,979
76,838
57,088
Net Income from Continuing & Discontinued Operation
-4,390
-10,585
-9,498
-188,890
-17,763
Normalized Income
-4,390
-10,585
-9,022.9100
-14,584.9242
91
Interest Income
--
1,906
7,006
6,703
23,544
Interest Expense
3,977
4,466
3,671
1,972
673
Net Interest Income
-2,071
-2,560
3,335
4,731
22,871
EBIT
-2,540
-8,328
-5,786
-24,088
509
EBITDA
-610
-6,144
-2,790
-16,757
6,238
Reconciled Cost of Revenue
44,348
45,573
38,956
40,602
23,266
Reconciled Depreciation
1,930
2,184
2,996
7,331
5,729
Net Income from Continuing Operation Net Minority Interest
-4,390
-10,585
-9,498
-22,511
91
Total Unusual Items Excluding Goodwill
0
0
-617
-8,288
0
Total Unusual Items
0
0
-617
-8,288
0
Normalized EBITDA
-610
-6,144
-2,173
-8,469
6,238
Tax Rate for Calcs
0.0001
0.0001
0.0002
0
0.0002
Tax Effect of Unusual Items
0
0
-141.9100
-361.9242
0
12/31/2021 - 5/20/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IXHL Incannex Healthcare Inc.
0.1994
-5.05%
QNTM Quantum BioPharma Ltd.
15.20
+12.93%
SCYX SCYNEXIS, Inc.
0.8896
+1.66%
FLGC Flora Growth Corp.
0.6400
-4.48%
RGC Regencell Bioscience Holdings Limited
747.99
-14.71%
CRON Cronos Group Inc.
1.9200
-3.03%
SXTC China SXT Pharmaceuticals, Inc.
1.3200
-5.04%
CGC Canopy Growth Corporation
1.2100
-8.33%
PTPI Petros Pharmaceuticals, Inc.
0.0345
-4.17%
CURLF Curaleaf Holdings, Inc.
0.8275
-0.30%